These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32756496)

  • 1. Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Disease (uILD): Long-Term Follow-Up Data from European IPF Registry (eurIPFreg).
    Krauss E; El-Guelai M; Pons-Kuehnemann J; Dartsch RC; Tello S; Korfei M; Mahavadi P; Breithecker A; Fink L; Stoehr M; Majeed RW; Seeger W; Crestani B; Guenther A
    J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32756496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unclassifiable-interstitial lung disease: Outcome prediction using CT and functional indices.
    Jacob J; Bartholmai BJ; Rajagopalan S; Egashira R; Brun AL; Kokosi M; Nair A; Walsh SLF; Karwoski R; Nicholson AG; Hansell DM; Wells AU
    Respir Med; 2017 Sep; 130():43-51. PubMed ID: 29206632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
    Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
    Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the Effectiveness of Pirfenidone in Idiopathic Pulmonary Fibrosis: Long-Term, Real-World Data from European IPF Registry (eurIPFreg).
    Krauss E; Tello S; Wilhelm J; Schmidt J; Stoehr M; Seeger W; Dartsch RC; Crestani B; Guenther A
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33266405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis.
    Guenther A; Krauss E; Tello S; Wagner J; Paul B; Kuhn S; Maurer O; Heinemann S; Costabel U; Barbero MAN; Müller V; Bonniaud P; Vancheri C; Wells A; Vasakova M; Pesci A; Sofia M; Klepetko W; Seeger W; Drakopanagiotakis F; Crestani B
    Respir Res; 2018 Jul; 19(1):141. PubMed ID: 30055613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF).
    Krauss E; Gehrken G; Drakopanagiotakis F; Tello S; Dartsch RC; Maurer O; Windhorst A; von der Beck D; Griese M; Seeger W; Guenther A
    BMC Pulm Med; 2019 Jul; 19(1):130. PubMed ID: 31319833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidities in unclassifiable interstitial lung disease.
    Prior TS; Hyldgaard C; Torrisi SE; Kronborg-White S; Ganter C; Bendstrup E; Kreuter M
    Respir Res; 2022 Mar; 23(1):59. PubMed ID: 35296320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of pulmonary function and usual interstitial pneumonia computed tomography patterns in idiopathic pulmonary fibrosis.
    Arcadu A; Byrne SC; Pirina P; Hartman TE; Bartholmai BJ; Moua T
    Respir Med; 2017 Aug; 129():152-157. PubMed ID: 28732823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.
    Traila D; Oancea C; Tudorache E; Mladinescu OF; Timar B; Tudorache V
    J Int Med Res; 2018 Jan; 46(1):448-456. PubMed ID: 28758849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a
    Molina-Molina M; Kreuter M; Cottin V; Corte TJ; Gilberg F; Kirchgaessler KU; Axmann J; Maher TM
    Front Med (Lausanne); 2022; 9():897102. PubMed ID: 35783648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging.
    Chung JH; Adegunsoye A; Cannon B; Vij R; Oldham JM; King C; Montner SM; Thirkateh P; Barnett S; Karwoski R; Bartholmai BJ; Strek M; Nathan SD
    J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34204184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and Incidence of PF-ILD According to Different Definitions in a Real-World Setting.
    Torrisi SE; Kahn N; Wälscher J; Polke M; Lee JS; Molyneaux PL; Sambataro FM; Heussel CP; Vancheri C; Kreuter M
    Front Pharmacol; 2021; 12():790204. PubMed ID: 34975486
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and prognosis of unclassifiable interstitial lung disease.
    Ryerson CJ; Urbania TH; Richeldi L; Mooney JJ; Lee JS; Jones KD; Elicker BM; Koth LL; King TE; Wolters PJ; Collard HR
    Eur Respir J; 2013 Sep; 42(3):750-7. PubMed ID: 23222877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Regional Pulmonary Ventilation in Spontaneously Breathing Patients with Idiopathic Pulmonary Fibrosis (IPF) Employing Electrical Impedance Tomography (EIT): A Pilot Study from the European IPF Registry (eurIPFreg).
    Krauss E; van der Beck D; Schmalz I; Wilhelm J; Tello S; Dartsch RC; Mahavadi P; Korfei M; Teschner E; Seeger W; Guenther A
    J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33430489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
    Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H
    Respir Med; 2019; 154():122-126. PubMed ID: 31238182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF].
    Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286
    [No Abstract]   [Full Text] [Related]  

  • 19. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial.
    Maher TM; Corte TJ; Fischer A; Kreuter M; Lederer DJ; Molina-Molina M; Axmann J; Kirchgaessler KU; Cottin V
    BMJ Open Respir Res; 2018; 5(1):e000289. PubMed ID: 30233802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.